the precise solution by sfm
In this blog you will regularly receive information about the product group nextaro®. The focus is on the reconstitution of lyophilized drugs, the problems and our solutions. In addition, special requirements of users and operators are also considered. We wish you much satisfaction and interest in exploring the nextaro® product group.
How can a mixing and transfer device offer users more benefits and enhance usability through optimized user-friendliness? These were the questions we thoroughly considered when embarking on the development of the nextaro® product family.
The nextaro® product family continues to grow steadily. The new developments are oriented towards the wishes and needs of the market. The focus of the product family lies in the highest quality solutions for the user and patient.
We are pleased to announce that our innovative medical product nextaro® has been successfully approved in Canada. This further milestone represents an important step in our international expansion and confirms the quality and recognition of our product.
Medical device approval in Canada requires…
In recent years, sustainability has become increasingly important in the medical industry. In particular, companies are increasingly focusing on the development and manufacture of sustainable medical products.
The current Covid-19 pandemic poses great challenges for the world. The situation should be controllable with global vaccination programs, but it will require an enormous logistic effort in terms of transport, storage and administration of the vaccines. How can freeze-dried vaccines simplify these…
Top off your high quality application set with the device it deserves.
Please do not hesitate to contact us.
nextaro® is manufactured and distributed by:
sfm medical devices GmbH, Brückenstraße 5, 63607 Wächtersbach (Germany)
